Profil
Jürgen Beck worked as Co-Managing Director at Paion Deutschland GmbH, Senior Vice President-Medical Affairs at Epigenomics AG, Vice President-Clinical & Medical Affairs at PROMETHERA Biosciences SA, and Vice President-Clinical Operations Europe at InterMune International AG.
He also served as Chief Development Officer at PAION AG from 2018 to 2020.
Beck holds an undergraduate and doctorate degree from Ruprecht-Karls-Universität Heidelberg, an undergraduate degree from Humboldt-Universität zu Berlin, and an MBA from the University of Hagen.
Anciens postes connus de Jürgen Beck
| Sociétés | Poste | Fin |
|---|---|---|
| PAION AG | Corporate Officer/Principal | 31/12/2020 |
| InterMune International AG | Corporate Officer/Principal | - |
Paion Deutschland GmbH
 Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Directeur Général | - |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Directeur Technique/Scientifique/R&D | - |
| EPIGENOMICS AG | Directeur Technique/Scientifique/R&D | - |
Formation de Jürgen Beck
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
| University of Hagen | Masters Business Admin |
| Humboldt-Universität zu Berlin | Undergraduate Degree |
| Julius-Maximilians-Universität Würzburg | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PAION AG | Health Technology |
| EPIGENOMICS AG | Health Technology |
| Entreprise privées | 3 |
|---|---|
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Health Technology |
Paion Deutschland GmbH
Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Health Technology |
| InterMune International AG |
